Public awareness of Crohn's disease and ulcerative colitis: A national survey

Journal of Crohn's and Colitis

Volumn 3, Issue 3, 2009, Pages 157-161

  Angelberger, Sieglinde ^a   Vogelsang, Harald ^a   Novacek, Gottfried ^a   Miehsler, Wolfgang ^a   Dejaco, Clemens ^a   Gangl, Alfred ^a   Reinisch, Walter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Crohn's disease; Public awareness; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUSTRIA; CONTROLLED STUDY; CROHN DISEASE; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; MEDICAL INFORMATION; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIOECONOMICS; ULCERATIVE COLITIS;

EID: 67749092938     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.01.003     Document Type: Article

References (14)

1. Hanauer S.B. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12 Suppl 1 (2006) 3-9
2. Ghosh S., and Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Association (EFCCA) patient survey. J Crohn's Colitis 1 (2007) 10-20
3. de Rooy E.C., Toner B.B., Maunder R.G., et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 96 6 (2001) 1816-1821
4. Frangos C.C., and Frangos C.C. Inflammatory bowel disease: reviewing an old study under a new perspective. Gut 56 (2007) 1638-1639
5. Prinz G., Novacek G., and Vogelsang H. Time to diagnosis in IBD patients belonging to a self-help group. J Crohn's Colitis 1 Suppl (2007) 26,P090 (abstract)
6. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
7. Stark R., König H.H., and Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 24 (2006) 797-814
8. Jackson D.M., Wills R., Davies J., et al. Public awareness of the symptoms of diabetes mellitus. Diabet Med 8 (1991) 971-972
9. Penn N.D., Stevenson C., McMahon C., et al. The effect of a city-wide mass media campaign on the public awareness of diabetes. Diabet Med 9 (1992) 756-758
10. Cosnes J., Cattan S., Blain A., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 8 (2002) 244-250
11. Munkholm P., Langholz E., Davidsen M., et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 105 (1993) 1716-1723
12. D'Haens G., Baert F., van Assche G., et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371 (2008) 660-667
13. Hanauer S.B., Feagan B.G., Lichtenstein G.R., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359 (2002) 1541-1549
14. Rutgeerts P., Diamond R.H., Bala M., et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 63 (2006) 433-442